RYTM
$22.33
Rhythm Pharmaceuticals
($1.05)
(4.49%)
RYTM
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.94)
Revenue:  $0.00 Mil
Friday
Oct 30
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RYTM reports earnings?
Beat
Meet
Miss

Where is RYTM's stock price going from here?
Up
Flat
Down
Stock chart of RYTM
Analysts
Summary of analysts' recommendations for RYTM
Score
Grade
Pivots
Resistance
$26.14
$25.57
$24.47

$23.90

Support
$22.80
$22.23
$21.13
Tweet
Growth
Description
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which result in life-threatening metabolic disorders. The Company's product candidate principally consists of setmelanotide, a potent, first-in-class melanocortin-4 receptor or MC4R, agonist for the treatment of rare genetic disorders of obesity. Rhythm Pharmaceuticals, Inc. is based in Boston, MA.